Lubricant formulation of carbamoylethyl katira and a process for preparation thereof

• US 10,639,274 B2
• Filed: 08/05/2016
• Issued: 05/05/2020
• Est. Priority Date: 08/07/2015
• Status: Active Grant

• Current Assignee: Council of Scientific & Industrial Research
• Original Assignee: Council of Scientific & Industrial Research
• Inventors: Rana, Vikas, Sharma, Radhika, Kamboj, Sunil, Singh, Kuldeep, Suresh, Sarasija
• Primary Examiner(s): Shiao, Yih-Horng
• Application Number:
  US15/751,115
• Publication Number:
  US 20180235873A1
• Time in Patent Office: 1,369 Days
• Field of Search: 514 54
• CPC Class Codes: A61K 31/715 Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
• CPC Class Codes: A61K 47/36 Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
• CPC Class Codes: A61K 9/0048 Eye, e.g. artificial tears

Abstract

A lubricant formulation of carbamoylethyl katira and a microwave assisted process for the preparation of the lubricant formulation of carbamoylethyl katira. The lubricant formulation of carbamoylethyl katira having antibacterial activity useful for eye lubricant based formulations, treatment of dry eye disease syndrome, etc.

Claims

1. A sterile lubricant formulation comprising:

carbamoylethyl katira, prepared from a katira gum, in the range of 2.5% w/v to 10% w/v;

sterile water; and

additives,

wherein said formulation shows antibacterial activity.

2. The sterile lubricant formulation as claimed in claim 1, wherein the katira gum is obtained from Cochlospermum religiosum.

3. The sterile lubricant formulation as claimed in claim 1, wherein the additives are selected from the group consisting of sodium chloride, a surfactant, another agent as an emulsifier, and combinations thereof, in a water based emulsion.

4. The sterile lubricant formulation as claimed in claim 1, wherein said formulation shows antibacterial activity against Staphylococcus aureus.

5. The sterile lubricant formulation as claimed in claim 1, wherein said formulation is suitable for use in treatment of dry eye disease.

6. A process for the preparation of the sterile lubricant formulation of claim 1, wherein said process comprises of the following steps:

a) soaking a katira gum in water for a time period of 14 to 20 hrs to obtain a homogenized gel;

b) stirring the homogenized gel obtained in step (a) for 30 to 45 minutes followed by addition of 25 ml of a 28% w/v to 44% w/v ice cold sodium hydroxide solution with stirring and additional stirring for 30 min after the addition of the ice cold sodium hydroxide solution to obtain a basic reaction mixture;

c) adding 11% w/v to 18% w/v of acrylamide to the basic reaction mixture obtained in step (b) with constant stirring for 1 hr to obtain a reaction mixture;

d) irradiating the reaction mixture obtained in step (c) in a microwave reactor at 450 watt for a time period of 0.5 to 1 min followed by a cooling cycle for a time period of 1 to 2 min at a temperature of 4°

C. to 10°

C. in ice bath;

e) repeating the step (d) for 3 to 7 times followed by neutralization with dilute glacial acetic acid to obtain a neutralized reaction mixture;

f) precipitating the neutralized reaction mixture obtained in step (e) with solvents followed by washing with a precipitating solvent to obtain a precipitate of carbamoylethyl katira;

g) filtering and drying the precipitate of carbamoylethyl katira obtained in step (f) to obtain a dried carbamoylethyl katira;

h) dissolving 2.5% to 10% w/v of dried carbamoylethyl katira obtained in step (g) in luke warm sterile water followed by filtration through a 0.22 μ

m filtration system to form a lubrication formulation of carbamoylethyl katira, filled in a sterilized vial and sealed; and

i) sterilizing the lubricant formulation of carbamoylethyl katira obtained in step (h) at a temperature in the range of 118°

C. to 121°

C. for a time period of 20 to 40 minutes to obtain said sterilized lubricant formulation of claim 1.

7. The process as claimed in claim 6, wherein the ratio of glacial acetic acid and water as diluent in step (e) is 1:

1 for neutralization of reaction.

8. The process as claimed in claim 6, wherein drying of carbamoylethyl katira in step (g) is carried out using lyophilization at a temperature in the range of −

80°

C. for a time period of 72 to 96 hours, or oven drying at a temperature of 45 to 55°

C. for a time period of 3.5 to 4.5 days or 60°

C. for a time period of 1.5 to 2.5 days to obtain the dried carbamoylethyl katira.

9. The process as claimed in claim 6, wherein the sterilizing in step (i) comprises autoclaving at temperature in the range of 118-121°

C. and a pressure of 15 psi to obtain sterilized lubricant formulation.

10. The sterile lubricant formulation as claimed in claim 1, wherein said formulation is in the form of a drop, the drop being formed by dropper bottle having a dropper Tip A with an orifice diameter of 0.45 mm or a dropper Tip B with an orifice diameter of 0.70 mm.

11. The sterile lubricant formulation as claimed in claim 10, wherein a weight of the drop is in the range of 35.4-81 mg and a volume of the drop is in the range of 35-79 μ

L being formed by the dropper Tip A.

12. The sterile lubricant formulation as claimed in claim 10, wherein a weight of the drop is in the range of 42-85 mg and a volume of the drop is in the range of 42-83 μ

L being formed by the dropper Tip B.

13. The sterile lubricant formulation of claim 1, wherein the formulation is a non-irritant with a zero irritation score.

14. A sterile ocular solution comprising carbamoylethyl katira prepared from a katira gum, in the range of 2.5% to 10% w/v, sterile water and a pH adjusting agent;

wherein said sterile ocular solution shows antibacterial activity.